Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Return on Sales (2020 - 2025)

Historic Return on Sales for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to 0.0%.

  • LifeStance Health's Return on Sales rose 200.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.05% for FY2024, which is 1300.0% up from last year.
  • LifeStance Health's Return on Sales amounted to 0.0% in Q3 2025, which was up 200.0% from 0.01% recorded in Q2 2025.
  • LifeStance Health's 5-year Return on Sales high stood at 0.0% for Q3 2025, and its period low was 0.69% during Q3 2021.
  • For the 5-year period, LifeStance Health's Return on Sales averaged around 0.19%, with its median value being 0.16% (2023).
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -6600bps in 2021, then skyrocketed by 5200bps in 2022.
  • Quarter analysis of 5 years shows LifeStance Health's Return on Sales stood at 0.57% in 2021, then skyrocketed by 64bps to 0.2% in 2022, then grew by 21bps to 0.16% in 2023, then soared by 85bps to 0.02% in 2024, then soared by 112bps to 0.0% in 2025.
  • Its last three reported values are 0.0% in Q3 2025, 0.01% for Q2 2025, and 0.0% during Q1 2025.